Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323868 · ClinicalTrials.gov registry record
Endogenous Endophthalmitis in the Inpatient Setting
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 145
- Enrollment target
NCT01323868: Completed study, sponsored by Stanford University.
NCT01323868 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323868 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01323868
The ClinicalTrials.gov registry entry for NCT01323868 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01323868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01323868 about?
NCT01323868 is a clinical study titled "Endogenous Endophthalmitis in the Inpatient Setting". The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
What is the current status of trial NCT01323868?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2010-07. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01323868?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.